|
1
|
Leivo I: Intestinal-type adenocarcinoma:
Classification, immunophenotype, molecular features and
differential diagnosis. Head Neck Pathol. 11:295–300. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baptista Freitas M, Costa M, Freire Coelho
A, Rodrigues Pereira P, Leal M, Sarmento C, Águas L and Barbosa M:
Sinonasal adenocarcinoma: Clinicopathological characterization and
prognostic factors. Cureus. 16:e560672024.PubMed/NCBI
|
|
3
|
Kennedy MT, Jordan RCK, Berean KW and
Perez-Ordoñez B: Expression pattern of CK7, CK20, CDX-2, and villin
in intestinal-type sinonasal adenocarcinoma. J Clin Pathol.
57:932–937. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leivo I: Sinonasal adenocarcinoma: Update
on classification, immunophenotype and molecular features. Head
Neck Pathol. 10:68–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eggesbø HB: Imaging of sinonasal tumours.
Cancer Imaging. 12:136–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rampinelli V, Ferrari M and Nicolai P:
Intestinal-type adenocarcinoma of the sinonasal tract: An update.
Curr Opin Otolaryngol Head Neck Surg. 26:115–121. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siddiqui F, Smith RV, Yom SS, Beitler JJ,
Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, et al:
ACR appropriateness criteria® nasal cavity and paranasal
sinus cancers. Head Neck. 39:407–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meccariello G, Deganello A, Choussy O,
Gallo O, Vitali D, De Raucourt D and Georgalas C: Endoscopic nasal
versus open approach for the management of sinonasal
adenocarcinoma: A pooled-analysis of 1826 patients. Head Neck. 38
(Suppl 1):E2267–E2274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vermassen T, De Keukeleire S, Saerens M,
Heerwegh S, Debacker JM, Huvenne W, Deron P, Creytens D, Ferdinande
L, Rottey S, et al: Choice of surgery in intestinal-type
adenocarcinoma of the sinonasal tract: A long-term comparative
study. Eur Arch Otorhinolaryngol. 281:2993–3004. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Keizer ME, Hovinga KE, Lacko M, Eekers
DBP, Baijens LWJ, Kremer B and Temel Y: Clinical outcome in
patients with large sinonasal tumors with intracranial extension. J
Neurol Surg B Skull Base. 85:347–357. 2023.PubMed/NCBI
|
|
11
|
Licitra L, Suardi S, Bossi P, Locati LD,
Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantù G, et
al: Prediction of TP53 status for primary cisplatin, fluorouracil,
and leucovorin chemotherapy in ethmoid sinus intestinal-type
adenocarcinoma. J Clin Oncol. 22:4901–4906. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sarradin V, Betrian S, Chaltiel L, Brac De
La Perriere C and Delord JP: 5-Fluorouracil with oxaliplatin and/or
irinotecan for advanced sinonasal intestinal-type adenocarcinoma
(ITAC). Bull Cancer. 110:168–173. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bossi P, Perrone F, Miceli R, Cantù G,
Mariani L, Orlandi E, Fallai C, Locati LD, Cortelazzi B, Quattrone
P, et al: Tp53 status as guide for the management of ethmoid sinus
intestinal-type adenocarcinoma. Oral Oncol. 49:413–419. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szablewski V, Solassol J, Poizat F,
Larrieux M, Crampette L, Mange A, Bascoul-Mollevi C and Costes V:
EGFR expression and KRAS and BRAF mutational status in
intestinal-type sinonasal adenocarcinoma. Int J Mol Sci.
14:5170–5181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hermsen MA, Riobello C, García-Marín R,
Cabal VN, Suárez-Fernández L, López F and Llorente JL:
Translational genomics of sinonasal cancers. Semin Cancer Biol.
61:101–109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Le X, Ferrarotto R, Wise-Draper T and
Gillison M: Evolving role of immunotherapy in recurrent metastatic
head and neck cancer. J Natl Compr Cancer Netw. 18:899–906. 2020.
View Article : Google Scholar
|
|
17
|
Harrington KJ, Burtness B, Greil R,
Soulières D, Tahara M, de Castro G Jr, Psyrri A, Brana I, Basté N,
Neupane P, et al: Pembrolizumab with or without chemotherapy in
recurrent or metastatic head and neck squamous cell carcinoma:
Updated results of the phase III KEYNOTE-048 study. J Clin Oncol.
41:790–802. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
André T, Shiu KK, Kim TW, Jensen BV,
Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Alcaide-Garcia J,
Gibbs P, et al: Pembrolizumab versus chemotherapy in microsatellite
instability-high or mismatch repair-deficient metastatic colorectal
cancer: 5-year follow-up from the randomized phase III KEYNOTE-177
study. Ann Oncol. 36:277–284. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Riobello C, Vivanco B, Reda S,
López-Hernández A, García-Inclán C, Potes-Ares S, Cabal VN, López
F, Llorente JL and Hermsen MA: Programmed death ligand-1 expression
as immunotherapeutic target in sinonasal cancer. Head Neck.
40:818–827. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thomas Z, Jambunathan P, Jibi A, John AO
and Singh A: Low-dose nivolumab and cabozantinib in recurrent
intestinal-type papillary adenocarcinoma of the sinonasal region.
BMJ Case Rep. 16:e2550212023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang L, Lu L, Ma J, Xu Z and Li N: A case
of high-grade non-intestinal paranasal sinus adenocarcinoma primary
in the maxillary sinus: Targeted therapy after postoperative
immunocombination with chemotherapy. J Cancer Res Clin Oncol.
150:3812024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paver EC, Cooper WA, Colebatch AJ,
Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L,
Scolyer RA and Gupta R: Programmed death ligand-1 (PD-L1) as a
predictive marker for immunotherapy in solid tumours: A guide to
immunohistochemistry implementation and interpretation. Pathology.
53:141–156. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang EI, Lu A, Tsai YT, Wang TC, Chuang
HC, Chen WC and Chen PT: Decreasing recurrence and increasing
survival rates in patients of ethmoid or sphenoid intestinal-type
adenocarcinomas: Systematic review and meta-analysis with 1126
cases. Medicine (Baltimore). 100:e273412021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Riobello C, Sánchez-Fernández P, Córdoba
MCC, González-Gutiérrez M, Vivanco B, Cabal VN, Fernández LS,
García-Marín R, Codina-Martínez H, Lorenzo-Guerra SL, et al:
Next-generation sequencing reveals remarkable genetic stability in
primary and corresponding recurrent intestinal-type sinonasal
adenocarcinoma. Head Neck. 46:2010–2019. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abu-Shama Y, Renard S, Nguyen DT, Henrot
P, Toussaint B, Rumeau C, Gallet P and Jankowski R: Descriptive
analysis of recurrences of nasal intestinal-type adenocarcinomas
after radiotherapy. Head Neck. 44:1356–1367. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parys QA, De Witte M, Hauben E, Clement
PM, Hermans R, Decramer T, van Loon J, Nuyts S, Jorissen M, Vander
Poorten V and Van Gerven L: Long-term outcomes of endoscopic
resection and tailored adjuvant radiotherapy for sinonasal
intestinal-type adenocarcinoma: A historical single-center cohort
study in 200 patients. Front Oncol. 15:15221132025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Wang T, Zhao K, Li Y and Song X: A
retrospective analysis of patients with primary sinonasal
adenocarcinoma underwent radiotherapy running title: Radiotherapy
for sinonasal adenocarcinoma. Sci Rep. 15:371152025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsu YC, Lu TY, Huang CJ and Huang MY:
Intensity-modulated radiation therapy for a sinonasal
intestinal-type adenocarcinoma patient: A rare case report. Ther
Radiol Oncol. 1:32017. View Article : Google Scholar
|
|
29
|
Hoeben A, van de Winkel L, Hoebers F,
Kross K, Driessen C, Slootweg P, Tjan-Heijnen VC and van Herpen C:
Intestinal-type sinonasal adenocarcinomas: The road to molecular
diagnosis and personalized treatment. Head Neck. 38:1564–1570.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Antognoni P, Turri-Zanoni M, Gottardo S,
Molteni M, Volpi L, Facco C, Freguia S, Mordacchini C, AlQahtani A,
Bignami M, et al: Endoscopic resection followed by adjuvant
radiotherapy for sinonasal intestinal-type adenocarcinoma:
Retrospective analysis of 30 consecutive patients. Head Neck.
37:677–684. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Askoxylakis V, Hegenbarth P, Timke C,
Saleh-Ebrahimi L, Debus J, Röder F and Huber PE: Intensity
modulated radiation therapy (IMRT) for sinonasal tumors: A single
center long-term clinical analysis. Radiat Oncol. 11:172016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dagan R, Uezono H, Bryant C, Holtzman AL,
Morris CG and Mendenhall WM: Long-term outcomes from proton therapy
for sinonasal cancers. Int J Part Ther. 8:200–212. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mirandola A, Russo S, Bonora M, Vischioni
B, Camarda AM, Ingargiola R, Molinelli S, Ronchi S, Rossi E, Vai A,
et al: A patient selection approach based on NTCP models and DVH
parameters for definitive proton therapy in locally advanced
sinonasal cancer patients. Cancers (Basel). 14:26782022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saito T, Ishikawa H, Ohnishi K, Aihara T,
Mizumoto M, Fukumitsu N, Sugawara K, Okumura T and Sakurai H:
Proton beam therapy for locally advanced and unresectable (T4bN0M0)
squamous cell carcinoma of the ethmoid sinus: A report of seven
cases and a literature review. Oncol Lett. 10:201–205. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jensen AD, Nikoghosyan AV, Ecker S,
Ellerbrock M, Debus J and Münter MW: Carbon ion therapy for
advanced sinonasal malignancies: Feasibility and acute toxicity.
Radiat Oncol. 6:302011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma KL, Mitchell TC, Dougher M, Sharon CE,
Tortorello GN, Elder DE, Morgan EE, Gimotty PA, Huang AC, Amaravadi
RK, et al: Tumor-infiltrating lymphocytes in necrotic tumors after
melanoma neoadjuvant anti-PD-1 therapy correlate with pathologic
response and recurrence-free survival. Clin Cancer Res.
30:4987–4994. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Larionova I, Cherdyntseva N, Liu T,
Patysheva M, Rakina M and Kzhyshkowska J: Interaction of
tumor-associated macrophages and cancer chemotherapy.
Oncoimmunology. 8:15960042019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Melero I, Castanon E, Alvarez M, Champiat
S and Marabelle A: Intratumoural administration and tumour tissue
targeting of cancer immunotherapies. Nat Rev Clin Oncol.
18:558–576. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lesterhuis WJ, Punt CJA, Hato SV,
Eleveld-Trancikova D, Jansen BJ, Nierkens S, Schreibelt G, de Boer
A, Van Herpen CM, Kaanders JH, et al: Platinum-based drugs disrupt
STAT6-mediated suppression of immune responses against cancer in
humans and mice. J Clin Invest. 121:3100–3108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Y, Zhao J, Li R, Yao X, Dong X, Zhang R
and Li Y: Treatment options for tumor progression after initial
immunotherapy in advanced non-small cell lung cancer: A real-world
study. Neoplasia. 57:1010432024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dallan I, Fiacchini G, Tricò D, Barucco M,
Turri-Zanoni M, Ferrari M, Di Girolami L, Schiavo G, Emanuelli E,
Mattavelli D, et al: Sinonasal intestinal-type adenocarcinoma:
Multi-institutional retrospective analysis based on 440 patients
with long-term follow-up. Eur J Cancer. 226:1156232025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Camp S, Van Gerven L, Poorten VV, Nuyts S,
Hermans R, Hauben E and Jorissen M: Long-term follow-up of 123
patients with adenocarcinoma of the sinonasal tract treated with
endoscopic resection and postoperative radiation therapy. Head
Neck. 38:294–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van de Velde LJ, Breimer GE, Scheurleer
WFJ, de Ridder M, Devriese LA, Braunius WW, de Bree R, van Dijk BAC
and Rijken JA: Sinonasal intestinal-type adenocarcinoma in the
Netherlands: A nationwide study (2008–2022). Head Neck.
47:2531–2540. 2025. View Article : Google Scholar : PubMed/NCBI
|
